CNS Pharmaceuticals, Inc.
CNSP
$5.78
-$0.16-2.69%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -8.03% | -5.58% | -6.68% | 23.37% | 3.23% |
| Total Depreciation and Amortization | 286.84% | 21.62% | 8.82% | 8.82% | 8.57% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -89.73% | -89.94% | -86.75% | -84.88% | 25.10% |
| Change in Net Operating Assets | 148.73% | 139.78% | 149.94% | -354.02% | -249.06% |
| Cash from Operations | 35.69% | 11.33% | 19.29% | -14.47% | -93.92% |
| Capital Expenditure | -571.43% | -480.95% | -333.33% | -90.91% | -7.69% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -571.43% | -480.95% | -333.33% | -90.91% | -7.69% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -3.17% | -2.33% | 1.03% | 12.40% | 19.72% |
| Issuance of Common Stock | -29.87% | -80.89% | -39.95% | -10.99% | 261.60% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -113.41% | -108.05% | 1,322.16% | 435.19% | 478.70% |
| Cash from Financing | -32.39% | -82.50% | -36.74% | -5.53% | 295.15% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -26.16% | -182.54% | -87.50% | -52.33% | 481.60% |